Business
Notification of Interest
Notification of Interest.
About this update from Futura Medical Plc
[{"type":"text","content":"\n RNS Number : 4911O Futura Medical PLC 06 March 2009 \n \n\n\n\n\n\nFor immediate release \n\n\n6 March 2009\n\n\n\n\n\n\n\n\nFutura Medical plc\n('Futura' or 'the Company')\n\nNotification of Interest\n\nFutura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, was notified on 6 March 2009 that, following the purchase of shares in the Company on the same day, P Mahon holds 2,083,302 ordinary shares in Futura, representing 3.3% of the issued share capital of the Company. \n\n\n\nFor any further information please contact:\n\n\n\n\n\n\nFutura Medical plc\n\n\n\n\n\n\n\nJames Barder, Chief Executive\n\n\nTel: +44 (0) 1483 685 670\n\n\n\n\n\n\n\n\n\n\n\n\nmail to: [email protected]\n\n\nwww.futuramedical.co.uk \n\n\n\n\n\n\n\n\n\n\n\n\nCanaccord Adams\n\n\n\n\n\n\n\nRyan Gaffney / Adria Da Breo Richards\n\n\nTel: +44 (0) 20 7050 6500 \n\n\n\n\n\n\n\n\n\n\n\n\nFor media enquiries please contact: \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBuchanan Communications\n\n\n\n\n\n\n\nMark Court / Rebecca Skye Dietrich / Stasa Filiplic\n\n\nTel: +44 (0) 20 7466 5000\n\n\n\n\n \n\nNotes to Editors\n\nFutura Medical plc\n\nFutura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.\n\nFutura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.\n\nwww.futuramedical.co.uk\n\n\nThis information is provided by RNSThe company news service from the London Stock Exchange END HOLCKAKPABKDPNK \n ","length":5190,"tagName":"div"}]